Addressing the Global Challenges of Drug-Resistant Gonorrhea

Neisseria gonorrhoeae, the cause of the sexually transmitted disease gonorrhea, causes a high burden of disease and has become resistant to each of the first-line antibiotics used to treat it, including increasing resistance to ceftriaxone, the mainstay of treatment globally. With two new antibiotics recently approved for treatment, the increasing use of doxycycline post-exposure prophylaxis for bacterial sexually transmitted infections, and development of new diagnostics, we have new tools to deploy. But how best to do so remains unclear.

In this presentation, Professor Yonatan Grad will review recent advances in the diagnosis, treatment, and prevention of gonorrhea, and discuss emerging frameworks for optimizing implementation and rollout strategies in diverse healthcare settings.

This webinar is free and open to the public and will include time for audience Q&A.

Register

Speaker

Yonatan Grad, MD, PhD
Professor of Immunology and Infectious Diseases and Director, Center for Communicable Disease Dynamics, Harvard T.H. Chan School of Public Health; Faculty, Division of Infectious Diseases, Brigham and Women’s Hospital

Yonatan is Professor of Immunology and Infectious Diseases and Director of the Center for Communicable Disease Dynamics at the Harvard T.H. Chan School of Public Health, and faculty in the Division of Infectious Diseases at Brigham and Women’s Hospital. The Grad lab focuses on how to prepare and respond effectively to infectious disease threats through understanding interacting processes from microbial evolution through human ecology. The lab uses interdisciplinary methods, including microbial genetics, population genomics, and mathematical modeling to move across these scales, with goals of advancing clinical and public health practices. He works with public health institutions locally, nationally, and internationally, including serving on WHO guideline committees for sexually transmitted infections.

Global Health Research and Innovation Speaker Series

The Harvard Global Health Institute’s Global Health Research and Innovation Speaker Series showcases the latest scholarly and scientific advancements in global health across Harvard and beyond, to make cutting-edge research accessible to a diverse global audience, and to spark innovative solutions in the pursuit of health equity and improved health outcomes worldwide. The public series takes place virtually on the second Tuesday of each month from 12:00 to 12:45 pm ET. Each session will include a presentation by a featured speaker showcasing their innovative research in global health, followed by a moderated Q&A.

The Harvard Global Health Institute provides a platform for different perspectives and debates within the field of global health through a variety of media. The views expressed in these events and programs are solely those of the speakers, authors, researchers, and participating audience. As such, they do not speak for the institute or the university.